Efficacy of Seated Exercise on Functional Capacity and Quality of Life in Patients With Leukemia During Chemotherapy Cycles

ConditionLeukemia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age30-40
SponsorSuez University

About this trial

This study aims to evaluate the efficacy of seated exercise on functional capacity and quality of life in patients with leukemia during chemotherapy cycles Participants will receive efficacy of seated exercise on functional capacity and quality of life in patients with leukemia during chemotherapy cycles over a defined period. Outcomes will be assessed using Pulmonary function test, 6 min walk test and FACT- G questionnaire to determine improvements in quality of life in cancer patient rehabilitation special to diagnosed with leukemia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male patients with age ranges from 30 to 40 years.

All patients in this study will be on chemotherapy from at least one cycle as a treatment of leukemia.

All patients will be hemodynamically stable.

Patients are ambulant.

Disqualifiers

Lung cancer

History of any pulmonary disease.

Metastasis of lung , ribs and mediastinal structure.

Pulmonary pathology (e.g. acute respiratory distress syndrome, or exacerbation of chronic obstructive pulmonary disease).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Seated exercise

    Behavioral

    Participants in the intervention group will perform a structured seated exercise program during their chemotherapy cycles. The exercise program will consist of supervised, individualized seated exercises designed to improve functional capacity and quality of life. The exercise sessions will be performed according to the study protocol throughout the intervention period. Each session will consist of a five-minute warm up, 20 minutes of moderate intensity repetitive motion exercises, and a five -minute cool-down. Functional outcomes will be assessed before and after the exercise program. including maximum voluntary ventilation , six-minute walk test distance, and FACT- G quesionnaire.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Seated exercise groupExperimental treatment 1 intervention
Group B: control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

change in functional capacity

Functional capacity will be assessed by the six-minute walk test (6MWT) distance before and after the four week seated exercise programe.

Time frame
Baseline and after 4 weeks of intervention
2

change in quality of life

Quality of life will be assessed using the Functional Assessment of Cancer Therapy General (FACT-G) questionnaire before and after week seated exercise programe. the total FACT-G score ranges from 0 to 108, with higher scores indicating better quality of life

Time frame
Baseline and after 4 weeks of intervention

Secondary outcomes

1

Change in Maximum Voluntary Ventilation (MVV)

Change in Maximum Voluntary Ventilation (MVV) will be assessed before and after the four week seated exercise program

Time frame
Baseline and after 4 weeks of intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: